NCT03161847

Brief Summary

The objective of this study is to test a set of clinical outcome measures longitudinally in a cohort of OPMD patients to identify ones that show quantifiable change over time as the disease progresses. The investigators' goal is to delineate the natural history of OPMD.

Trial Health

15
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Dec 2016

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 12, 2016

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

May 16, 2017

Completed
6 days until next milestone

First Posted

Study publicly available on registry

May 22, 2017

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 18, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 18, 2018

Completed
Last Updated

May 27, 2022

Status Verified

May 1, 2017

Enrollment Period

1.6 years

First QC Date

May 16, 2017

Last Update Submit

May 23, 2022

Conditions

Keywords

OPMD

Outcome Measures

Primary Outcomes (1)

  • Muscle Strength over time

    Change in Manual muscle testing over time

    Baseline and every 9 months for 3 years

Secondary Outcomes (1)

  • Dysphagia severity over time

    Baseline and every 9 months for 3 years

Study Arms (1)

OPMD Subjects

The study cohort consists of individuals with genetically confirmed OPMD who will be followed longitudinally using periodic standardized assessments of clinical status in an observational, non-interventional study.

Other: Non-interventional study

Interventions

Non-interventional study

OPMD Subjects

Eligibility Criteria

Age18 Years - 99 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Genetically Confirmed Oculopharyngeal Muscular Dystrophy

You may qualify if:

  • OPMD by genetic criteria
  • ≥ 18 years old
  • English-speaking

You may not qualify if:

  • Another medical condition that precludes safe completion of study tasks (such as severe cardiac or respiratory disease)
  • Another medical condition that causes symptoms similar to OPMD (i.e., ptosis, dysphagia \[trouble swallowing\] or limb weakness).
  • History of head or neck cancer, or history of radiation to the head or neck
  • A videofluoroscopic swallow study within the 12 months prior to study enrollment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Muscular Dystrophy, Oculopharyngeal

Condition Hierarchy (Ancestors)

Muscular DystrophiesMuscular Disorders, AtrophicMuscular DiseasesMusculoskeletal DiseasesNeuromuscular DiseasesNervous System DiseasesGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Officials

  • Sarah Youssof, MD, MS

    New Mexico Neuromuscular Center

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 16, 2017

First Posted

May 22, 2017

Study Start

December 12, 2016

Primary Completion

July 18, 2018

Study Completion

July 18, 2018

Last Updated

May 27, 2022

Record last verified: 2017-05

Data Sharing

IPD Sharing
Will not share